Increased circulating CC chemokine levels in metabolic syndrome are reduced by low dose atorvastatin treatment: evidence from a randomised controlled trial.

Brona Loughrey, Ann McGinty, Ian Young, David McCance, Lesley Powell

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalClinical Endocrinology
Publication statusAccepted - 2013

Cite this